CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk Healthcare Brawn Biotech Ltd

Brawn Biotech Ltd

BSE 530207 BRAWN INE899B01015
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

6 filings · 2 material · busiest 2026-08-13

What it files

Filings

6 in the window

  1. 14 August 2026

    Newspaper Publication

    Newspaper Publication

    Publication of Un-audited financial results for the quarter ended June 30, 2026.

    Company Update / Newspaper Publication View filing →

  2. 13 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026 To Consider And Approve, Inter-Alia, Un-Audited Financial Results Of The Company For Quarter Ended June 30, 2026.

    Outcome of Board Meeting held on August 13, 2026 to consider and approve, inter-alia, un-audited financial results of the company for quarter ended June 30, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  3. 13 August 2026

    Results

    Outcome Of Board Meeting Held On August 13, 2026 To Consider And Approve, Inter-Alia, Un-Audited Financial Results Of The Company For Quarter Ended June 30, 2026.

    Outcome of Board Meeting held on August 13, 2026 to consider and approve, inter-alia, un-audited financial results of the company for quarter ended June 30, 2026.

    Result / Financial Results View filing →

  4. 5 August 2026

    Board Meeting

    Board Meeting Intimation for Consideration And Approval Of, Inter Alia, The Un-Audited Financial Results Of The Company For The Quarter Ended June 30, 2026.

    Brawn Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Un-Audited Financial Results ....

    Board Meeting / Board Meeting View filing →

  5. 8 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Reg 74(5)

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  6. 25 June 2026

    Trading Window

    Closure of Trading Window

    Closure of Trading Window for the quarter ended June 30, 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →